ArticleFrontiers in medicine2025
DCAI: a dual cross-attention integration framework for benign-malignant classification of pulmonary nodules.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Multitask deep learning models for ultrasound image analysis: identification of high-grade serous ovarian cancer and segmentation of tumor regions and intratumoral solid components.Journal of ovarian research · 2026Article
- Frequency response compensation to optimize pretrained deep learning models in lung nodule malignancy classification.Frontiers in artificial intelligence · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lung cancer remains a leading cause of cancer-related mortality worldwide, and accurate early identification of malignant pulmonary nodules is critical for improving patient outcomes. Although artificial intelligence (AI) technology has shown promise in pulmonary nodule benign-malignant classification, existing methods struggle with modality heterogeneity and limited exploitation of complementary information across modalities. To address the above issues, we propose a novel multimodal framework, the Dual Cross-Attention Integration framework (DCAI), for benign-malignant classification of pulmonary nodules. Specifically, we first convert 3D nodules into multiple 2D images and obtain nodule features annotated by clinical experts. These features are encoded using Transformer models, and then a dual cross-attention module is proposed to dynamically align and interact with the complementary information between the different modalities. The fused representations from both modalities are then concatenated for benign-malignant prediction. We evaluate our proposed method on the LIDC-IDRI dataset, and experimental results demonstrate that DCAI outperforms several existing multimodal methods, highlighting the effectiveness of our approach in improving the accuracy of pulmonary nodule benign-malignant classification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.